About Horizon Pharmaceuticals
Horizon Pharmaceuticals is a company based in West Palm Beach (United States) founded in 2008. Horizon Pharmaceuticals has raised $670.27 thousand across 2 funding rounds. Horizon Pharmaceuticals offers products and services including BFS Manufacturing Service, Formulation Development, and Custom Container Design. Horizon Pharmaceuticals operates in a competitive market with competitors including G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.
- Headquarter West Palm Beach, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Horizon Pharmaceuticals, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$670.27 K (USD)
in 2 rounds
-
Latest Funding Round
$32.77 K (USD), Seed
Feb 22, 2012
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Horizon Pharmaceuticals
Horizon Pharmaceuticals offers a comprehensive portfolio of products and services, including BFS Manufacturing Service, Formulation Development, and Custom Container Design.
Offers blow-fill-seal production for pharmaceuticals and devices
Provides research and scale-up for pharmaceutical formulations
Creates specialized containers for medical and diagnostic use
Funding Insights of Horizon Pharmaceuticals
Horizon Pharmaceuticals has successfully raised a total of $670.27K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $32.77 thousand completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Horizon Pharmaceuticals
Investment portfolio details for Horizon Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Horizon Pharmaceuticals
Detailed financials for Horizon Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Horizon Pharmaceuticals Comparisons
Peer comparison for Horizon Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Horizon Pharmaceuticals
Horizon Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Builds and installs prefabricated, autonomous cleanrooms
|
|
| Locked | Locked | Locked |
Protective equipment and containment systems for nuclear medicine, nuclear power plants and aseptic manufacturing
|
|
| Locked | Locked | Locked |
Laboratory safety equipment is manufactured for research and industrial use.
|
|
| Locked | Locked | Locked |
Developer of protective equipment against biological risks for research, pharma and hospital sectors
|
|
| Locked | Locked | Locked |
Radiation monitoring and protection
|
|
| Locked | Locked | Locked |
Anti-viral technology for face masks is developed by Virustatic.
|
Detailed competitors of Horizon Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Horizon Pharmaceuticals
Complete news archive for Horizon Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Horizon Pharmaceuticals
Horizon Pharmaceuticals was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Horizon Pharmaceuticals is headquartered in West Palm Beach, United States. It is registered at West Palm Beach, Florida, United States.
Horizon Pharmaceuticals is a funded company, having raised a total of $670.27K across 2 funding rounds to date.
Horizon Pharmaceuticals, Inc. is a company focused on the development, manufacture and life cycle management of Blow-Fill-Seal (BFS) products for the pharmaceutical, medical device, diagnostic and clinical industries.
Horizon Pharmaceuticals's top competitors include G-Con Manufacturing, Comecer and NuAire.
Horizon Pharmaceuticals offers BFS Manufacturing Service, Formulation Development, and Custom Container Design.